Finally, we screened potential drugs targeting DSN1 by drug sensitivity and molecular docking analyses.<h4>Results</h4>Bioinformatics analysis revealed that DSN1 is highly expressed in breast cancer, making it a potential diagnostic marker. The gene discussed is DSN1; the disease is breast carcinoma.